Next Article in Journal
Age-Related Sex Differences in Glucose Tolerance by 75 g Oral Glucose Tolerance Test in Japanese
Next Article in Special Issue
Components of the Fiber Diet in the Prevention and Treatment of IBD—An Update
Previous Article in Journal
Dietary Advice to Support Glycaemic Control and Weight Management in Women with Type 1 Diabetes during Pregnancy and Breastfeeding
Previous Article in Special Issue
The Role of Dietary Fibers in the Management of IBD Symptoms
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Editorial of the Special Issue “Dietary Fiber and Inflammatory Bowel Disease”

1
School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW 2007, Australia
2
Centre for Inflammation, Centenary Institute, Camperdown, NSW 2050, Australia
3
School of Population Health, University of New South Wales, Sydney, NSW 2052, Australia
*
Author to whom correspondence should be addressed.
Nutrients 2022, 14(22), 4861; https://doi.org/10.3390/nu14224861
Submission received: 26 October 2022 / Accepted: 9 November 2022 / Published: 17 November 2022
(This article belongs to the Special Issue Dietary Fiber and Inflammatory Bowel Disease)
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a chronic disease of the gastrointestinal (GI) tract; its burden has significantly increased in recent decades, with 6.8 million cases of IBD reported in 2017 according to the Global Burden of Disease study [1]. The exact cause of IBD remains unknown, although chronic gut inflammation has been found to be a key contributing factor in the development of IBD, resulting in tissue remodelling that damages the structure of the colon. Current treatments only slow its progression, with no imminent cure in sight; however, surgical resection to physically remove damaged areas in the GI tract is still considered the best option for the treatment of IBD, potentially calling for multiple surgeries due to the recurrence of the disease [2]. Therefore, a better understanding of IBD development and elucidation of its underpinned mechanisms could help explore novel therapeutic options for this disease.
Mucosal inflammation, immune cell infiltration and increased leukocytes are regularly observed in IBD patients, always associated with immune system malfunctions, including T helper (Th)2 and Th17 responses and abnormal levels of cytokines [3]. For example, the tumour necrosis factor (TNF) is a proinflammatory cytokine whose level tends to significantly increase in IBD patients [4]. Chronic inflammation in patients with IBD also results in structural cells (epithelial cells, fibroblasts and muscle cells) to secrete extracellular matrix (ECM) proteins, including collagen and fibronectin for wound healing [5]. However, the uncontrolled wound healing process in patients leads to the extensive deposition of ECM proteins and tissue remodelling/fibrosis that damages the structure and function of colon tissue.
The gut microbiome is essential in regulating the immune system in IBD patients, with studies having shown varying microbial diversities in IBD patients and healthy individuals. The maintenance of the balance of the gut microbiota is a novel insight in the treatment of IBD [6]. For example, faecal microbiota transplantation (FMT) has recently become a novel therapeutic concept, where functional microbiota are transplanted from faeces donated by healthy donors to IBD patients, for which many clinical trials are currently in progress [7].
Interestingly, IBD patients have presented with similar microbial changes to patients with COVID-19, characterised by gut issues, including diarrhea, vomiting and abdominal pain. This could potentially indicate a link between COVID-19 and IBD, but recent studies have shown that IBD patients have no increased risk of contracting COVID-19 [8]. The relationship between IBD and COVID-19, including their underpinned mechanisms, requires further discussion.
The rapid ageing of the population is a global phenomenon that entails the elderly people to be more prone to developing IBD. Biological aging results in cellular senescence that leads to immune dysfunction and chronic inflammation [9], a process that also significantly contributes to the progression of IBD.
Diet has been widely recognised as an important factor in the prevention and management of noncommunicable diseases (NCDs) [10,11,12,13,14,15], including IBD. Several pathways where the diet might influence intestinal inflammation have been proposed thus far, including direct dietary antigens being responsible for altering the gut microbiome and affecting gastrointestinal permeability [16].
Accumulating epidemiological and experimental studies have reported that diets rich in fibre or particular dietary patterns (e.g., plant-based diets) might help in the management of IBD [17]. However, more research comprising strong and robust evidence in support of effective dietary interventions in achieving better clinical outcomes among patients with IBD is needed.
In this Special Issue, manuscripts highlight creative and novel findings linking diet and IBD and present research to help advance the knowledge of how dietary fibre affects IBD in biomedical science, the population’s health and clinical practice.

Author Contributions

Conceptualization, G.L. and X.X.; writing–original draft preparation, G.L. and X.X.; and writing–review and editing, G.L. and X.X. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Alatab, S.; Sepanlou, S.G.; Ikuta, K.; Vahedi, H.; Bisignano, C.; Safiri, S.; Sadeghi, A.; Nixon, M.R.; Abdoli, A.; Abolhassani, H.; et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 2020, 5, 17–30. [Google Scholar] [CrossRef] [Green Version]
  2. Liu, G.; Mateer, S.W.; Hsu, A.; Goggins, B.J.; Tay, H.; Mathe, A.; Fan, K.; Neal, R.; Bruce, J.; Burns, G.; et al. Platelet activating factor receptor regulates colitis-induced pulmonary inflammation through the NLRP3 inflammasome. Mucosal Immunol. 2019, 12, 862–873. [Google Scholar] [CrossRef] [PubMed]
  3. Mateer, S.W.; Mathe, A.; Bruce, J.; Liu, G.; Maltby, S.; Fricker, M.; Goggins, B.J.; Tay, H.L.; Marks, E.; Burns, G.; et al. IL-6 Drives Neutrophil-Mediated Pulmonary Inflammation Associated with Bacteremia in Murine Models of Colitis. Am. J. Pathol. 2018, 188, 1625–1639. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Cui, G.; Fan, Q.; Li, Z.; Goll, R.; Florholmen, J. Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. EBioMedicine 2021, 66, 103329. [Google Scholar] [CrossRef] [PubMed]
  5. Goggins, B.J.; Minahan, K.; Sherwin, S.; Soh, W.S.; Pryor, J.; Bruce, J.; Liu, G.; Mathe, A.; Knight, D.; Horvat, J.C.; et al. Pharmacological HIF-1 stabilization promotes intestinal epithelial healing through regulation of α-integrin expression and function. Am. J. Physiol. Gastrointest. Liver Physiol. 2021, 320, G420–G438. [Google Scholar] [CrossRef] [PubMed]
  6. Pascal, V.; Pozuelo, M.; Borruel, N.; Casellas, F.; Campos, D.; Santiago, A.; Martinez, X.; Varela, E.; Sarrabayrouse, G.; Machiels, K.; et al. A microbial signature for Crohn’s disease. Gut 2017, 66, 813–822. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Haifer, C.; Paramsothy, S.; Kaakoush, N.O.; Saikal, A.; Ghaly, S.; Yang, T.; Luu, L.D.W.; Borody, T.J.; Leong, R.W. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): A randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol. Hepatol. 2022, 7, 141–151. [Google Scholar] [CrossRef]
  8. Shen, S.; Gong, M.; Wang, G.; Dua, K.; Xu, J.; Xu, X.; Liu, G. COVID-19 and Gut Injury. Nutrients 2022, 14, 4409. [Google Scholar] [CrossRef] [PubMed]
  9. Faye, A.S.; Colombel, J.F. Aging and IBD: A New Challenge for Clinicians and Researchers. Inflamm. Bowel Dis. 2022, 28, 126–132. [Google Scholar] [CrossRef] [PubMed]
  10. Xu, X.; Hall, J.; Byles, J.; Shi, Z. Dietary Pattern Is Associated with Obesity in Older People in China: Data from China Health and Nutrition Survey (CHNS). Nutrients 2015, 7, 8170–8188. [Google Scholar] [CrossRef] [PubMed]
  11. Xu, X.; Byles, J.; Shi, Z.; McElduff, P.; Hall, J. Dietary pattern transitions, and the associations with BMI, waist circumference, weight and hypertension in a 7-year follow-up among the older Chinese population: A longitudinal study. BMC Public Health 2016, 16, 743. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Xu, X.; Hall, J.; Byles, J.; Shi, Z. Dietary pattern, serum magnesium, ferritin, C-reactive protein and anaemia among older people. Clin. Nutr. 2017, 36, 444–451. [Google Scholar] [CrossRef] [PubMed]
  13. Xu, X.; Parker, D.; Shi, Z.; Byles, J.; Hall, J.; Hickman, L. Dietary Pattern, Hypertension and Cognitive Function in an Older Population: 10-Year Longitudinal Survey. Front. Public Health 2018, 6, 201. [Google Scholar] [CrossRef] [PubMed]
  14. Xu, X.; Parker, D.; Inglis, S.C.; Byles, J. Can regular long-term breakfast cereals consumption benefits lower cardiovascular diseases and diabetes risk? A longitudinal population-based study. Ann. Epidemiol. 2019, 37, 43–50.e3. [Google Scholar] [CrossRef] [PubMed]
  15. Xu, X.; Ling, M.; Inglis, S.C.; Hickman, L.; Parker, D. Eating and healthy ageing: A longitudinal study on the association between food consumption, memory loss and its comorbidities. Int. J. Public Health 2020, 65, 571–582. [Google Scholar] [CrossRef] [PubMed]
  16. Hou, J.K.; Lee, D.; Lewis, J. Diet and inflammatory bowel disease: Review of patient-targeted recommendations. Clin. Gastroenterol. Hepatol. 2014, 12, 1592–1600. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Green, N.; Miller, T.; Suskind, D.; Lee, D. A Review of Dietary Therapy for IBD and a Vision for the Future. Nutrients 2019, 11, 947. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Liu, G.; Xu, X. Editorial of the Special Issue “Dietary Fiber and Inflammatory Bowel Disease”. Nutrients 2022, 14, 4861. https://doi.org/10.3390/nu14224861

AMA Style

Liu G, Xu X. Editorial of the Special Issue “Dietary Fiber and Inflammatory Bowel Disease”. Nutrients. 2022; 14(22):4861. https://doi.org/10.3390/nu14224861

Chicago/Turabian Style

Liu, Gang, and Xiaoyue Xu. 2022. "Editorial of the Special Issue “Dietary Fiber and Inflammatory Bowel Disease”" Nutrients 14, no. 22: 4861. https://doi.org/10.3390/nu14224861

APA Style

Liu, G., & Xu, X. (2022). Editorial of the Special Issue “Dietary Fiber and Inflammatory Bowel Disease”. Nutrients, 14(22), 4861. https://doi.org/10.3390/nu14224861

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop